The Vertical Group is a New Jersey-based venture capital firm focused on the fields of medical technology and biotechnology.
The Vertical Group has made 51 investments as of 2018. Their most recent investment was on Mar 5, 2018, when Biorez raised $1.5M. The Vertical Group has had 14 exits. The Vertical Group's most notable exits include Silk Road Medical, OncoMed Pharmaceuticals, and TetraLogic Pharmaceuticals. The Vertical Group has raised a total of $10M in a single venture fund, Vertical Fund II. This fund was announced on Jan 23, 2006 and raised a total of $10M.